This inventor holds 2 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Pune, IN (2014)
- Maharashtra, IN (2016)
Company Filing History:
Years Active: 2014-2016
Title: **Shailaja Pramod Maybhate: Innovator in Anti-Tubercular Compounds**
Introduction
Shailaja Pramod Maybhate, located in Maharashtra, India, is a distinguished inventor known for her contributions to the field of medicinal chemistry. With two patents to her name, her work primarily focuses on the development of innovative compounds aimed at combating tuberculosis and other mycobacterial infections.
Latest Patents
Maybhate's most recent patents showcase her expertise in triazole derivatives. Her first patent involves 1, 2, 4-triazole derivatives and their anti-microbial activity, making significant strides as anti-tubercular compounds. This patent includes a detailed process for preparing these triazoles and a novel method for inhibiting the growth of Mycobacterium bovis BCG and H37Ra using the triazoles.
Her second patent also revolves around 1, 2, 4-triazole derivatives and emphasizes their anti-mycobacterial activity. This invention presents propargylated 1,2,3-triazoles as promising antitubercular compounds, providing the formula and structural specifications for various chemical configurations to enhance their efficacy against mycobacterial infections.
Career Highlights
Shailaja Pramod Maybhate is currently an integral part of the Council of Scientific & Industrial Research, a prestigious institution known for its innovative research and development efforts. Her role involves extensive research that contributes to the advancement of science and technology, particularly in the medical field.
Collaborations
Throughout her career, Maybhate has collaborated with esteemed colleagues like Dhiman Sarkar and Sunita Ranjan Deshpande. These collaborations foster an environment of innovation and allow for the cross-pollination of ideas that drive significant advancements in medicinal chemistry.
Conclusion
In summary, Shailaja Pramod Maybhate's contributions to the development of anti-tubercular compounds through her patents highlight her commitment to addressing critical health challenges. Her expertise and collaborative spirit continue to pave the way for innovative solutions in the fight against tuberculosis and related mycobacterial diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile